Sign in
Taking peopleNo phase

Blended Treatment för PTSD: A New Format of Computer-Assisted Trauma-Focused Cognitive Behavioral Therapy

Key facts

Who runs it
Karolinska Institutet
Where
Sweden1 site in 1 countryChoose a country to see its sites
Trial code
Status
Recruiting
People taking part
160 people, planned
Started
10 Mar 2023
Expected to end
10 Oct 2027
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Blended Trauma focused Cognitive Behavioral Therapy (B-Tf-CBT)
  • Prolonged exposure
Record updated
26 December 2025

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 11 criteriaShow less

Who can take part

  • PTSD according to Diagnostic and Statistical Manual of mental disorders 5 as primary problem
  • ≥ 18 years
  • Basic knowledge of speaking and writing Swedish
  • No other psychological treatment at the same time
  • No ongoing threats or violence
  • If antidepressant medication, stable dose 6 weeks before starting treatment
  • Have access to the internet and a computer
  • Willingness/ability to participate after receiving information about what participation entails

Who cannot take part

  • Other diagnosis or problem is assessed as primary to PTSD
  • Moderate to severe suicidal risk
  • PTSD from childhood trauma that the person cannot remember

This trial is currently available in Sweden.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

A Randomized Controlled Non-inferiority Trial testing if the new experimental Blended Trauma focused cognitive behavioral therapy (B-TF-CBT) for post traumatic stress disorder (PTSD), is non-inferior to gold standard control treatment Prolonged Exposure (PE).

Read full original descriptionShow less

Research question and hypothesis

Primary

1. Is bTF-CT non-inferior to prolonged exposure (PE) when delivered in routine clinical care in terms of PTSD symptoms on the PCL-5 post-treatment?

Secondary: 2. Is bTF-CT non-inferior to prolonged exposure (PE) when delivered in routine clinical care in terms of PTSD symptoms on the PCL-5 at 6 and 12 months follow up? 3. Are there significant differences between bTF-CT and PE when delivered in routine clinical care in terms of depression, anxiety, insomnia, functionality, complex PTSD, other PTSD-measures and treatment satisfaction post-treatment and at 6 and 12 months follow up?

The study will be conducted at 3-6 outpatient clinics in Region Stockholm, Sweden.

The 2 groups in the trial

  • Blended Trauma focused Cognitive Behavioral Therapy (B-Tf-CBT)Treatment being tested

    B-Tf-CBT shares key features with Internet-based CBT (I-CBT) in that it is based on a digital support accessible to the patient. This digital support equips blended treatment with the same proposed advantages as I-CBT in terms of improving treatment accessibility, adherence, and reducing therapist-time. In addition, incorporating 6 biweekly face-to-face sessions to facilitate and augment delivery of more demanding components of TF-CBT such as memory exposure.

  • Prolonged exposureExisting treatment, for comparison

    Gold standard Tf-CBT Prolonged exposure will constitute the control condition. Prolonged exposure will be delivered by trained therapists under supervision adhering to the evidence based manual delivered face-to-face over 9-15 weeks.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Evaluation of Blended CBT for PTSD in Regular Care: A New Format of Computer-Assisted Trauma-Focused Cognitive Behavioral Therapy: A Randomized Controlled Non-inferiority Trial
Record updated
26 December 2025